Supply and market disruption refers to coordinated strategies aimed at reducing the production, trafficking, distribution, and availability of illicit substances. These strategies often involve law enforcement, regulatory controls, border management, and financial investigations designed to disrupt drug trafficking networks and weaken illicit drug markets. By targeting supply chains and market dynamics, these efforts aim to reduce the availability of drugs, increase the risks and costs associated with illegal production and distribution, and contribute to broader efforts to reduce substance-related harms. Effective supply and market disruption typically operates alongside public health, prevention, treatment, and recovery responses as part of a comprehensive approach to substance use.
Supply & Market Disruption
International Narcotics Control Board (INCB), Precursors and chemicals frequently used in the illicit manufacture of narcotic drugs and psychotropic substances, United Nations, New York
The International Narcotics Control Board’s 2015 report on precursors highlights global efforts to stop chemicals being diverted into the illicit manufacture of drugs. It points to successes achieved through international cooperation...
Council of the European Union (2013d), The Council of the European Union
The Council of the European Union is the forum where national ministers from all EU countries come together to make decisions that shape Europe. It is responsible for negotiating and adopting EU laws, approving the budget, concluding...
Council of the European Union (2013c), EU‑CELAC Action Plan 2013–2015
The EU-CELAC Action Plan 2013–2015 sets out a framework for strengthened cooperation between the European Union and Latin American and Caribbean countries. Building on priorities agreed at the EU-LAC and EU-CELAC Summits, it focuses on key...
Council of the European Union (2013b), EU-Central Asia Action Plan on Drugs (2014–2020)
The European Union and Central Asian countries have joined forces through the EU–Central Asia Action Plan on Drugs 2014–2020, building on earlier cooperation dating back to 2002. This plan recognises the shared challenges posed by drug...
Council of the European Union (2013a), EU Action Plan on Drugs 2013–2016
In 2012, the Council of the European Union adopted the EU Drugs Strategy for 2013–2020, setting a long-term framework to reduce both drug demand and supply. To put this into practice, the Irish Presidency developed the first EU Drugs Action...
Council of the European Union (2012b), Consolidated versions of the Treaty on European Union and the Treaty on the Functioning of the European Union and the Charter of Fundamental Rights of the European Union
The Publications Office of the European Union provides open access to a broad collection of official EU works. Covering everything from policy updates and statistical analyses to educational tools and research findings, the platform gathers...
Council of the European Union (2012b), Consolidated versions of the Treaty on European Union and the Treaty on the Functioning of the European Union and the Charter of Fundamental Rights of the European Union
The Publications Office of the European Union offers free access to a wide range of official EU publications. From research reports and educational resources to policy overviews and statistical studies, the site brings together knowledge...
Council of the European Union (2012a), European Union Drugs Strategy 2013–2020
The EU Drugs Strategy (2013–2020) set out a shared political framework to guide the European Union’s approach to drugs policy. Grounded in the principles of EU law and international conventions, it focused on protecting public health...
The Future Of Drug Supply Monitoring In Europe (Poster)
his EMCDDA paper explores how better data can help us understand and respond to Europe’s illicit drug markets. Traditional indicators like seizures, prices, purity, and offences provide only part of the picture, so the agency is expanding...
Drug Supply Reduction: An Overview Of EU Policies And Measures
This EMCDDA paper introduces the European Union’s approach to drug supply reduction, explaining how policies, structures, and actions are designed to disrupt drug markets and limit the availability of illicit substances. It highlights the...